Welcome to CPR Pharma Services
CPR Pharma Services (‘CPR’) is a full-service CRO with an international reputation for delivering superior clinical trial results in Australia and Asia through our “Fast2PhaseOne” and “Access2Asia” services.
As the premier provider of early phase clinical trial services in the Asia Pacific region for over a decade, we have leveraged our extensive experience to now offer an expanded range of services. CPR can assist you to:
- Get your trial underway quickly and cost effectively via our Fast2PhaseOne service
- Confidently navigate entry into the Asian market via our Access2Asia service
- Provide bioanalytical support in the Asia-Pacific with Laboratories in Australia and Singapore
- Access the Australian Government’s attractive R&D Tax Incentive through our strategic partnership with one of Australia’s leading taxation experts
- Get your trial back on track through our Recovery Centre.
Please peruse our website to learn more about CPR and our team of experts, or contact us directly to discuss your specific requirements.
Get it right first time with CPR – the experts in early phase clinical research.
FDA Audit - Complex peptide no challenge for CPR scientists
With the in-life component of a clinical trial completed, a large multinational pharmaceutical company approached CPR to help develop a peptide assay to complete the bioanalysis to report data before an FDA deadline closed.
New Ligand Binding Assay Service - CPR expands APAC offering with large molecule analytical service
CPR's new laboratory, in Adelaide, Australia now offers best practice ligand binding assay services for biomarkers, monoclonal antibodies, biosimilars and biologics in early and late phase clinical trials – the first APAC based laboratory to offer such an extensive range of GLP services.
List of conferences we're attending
Take a virtual tour of our Singapore lab
CPR was recently featured on ABC's APAC Focus. Click here to watch the segment
Connect with us